C F is the most common lethal autosomal recessive disease trait found in the Caucasian population, occurring in approximately one of every 2000 live births. The carrier frequency has been estimated to be as high as 5% (1) . In the C F homozygote, the disease is characterized by chronic pulmonary disease accompanied by bacterial infection, pancreatic insufficiency associated with malabsorption and malnutrition, and an elevated sweat chloride level. CF heterozygotes appear to be clinically normal.
Although long sought, neither the basic biochemical abnormality nor the gene product of C F are known (2) (3) (4) (5) .
Increased oxygen uptake and mitochondria1 electron transport activity have been reported in the skin fibroblasts of both C F homozygotes and heterozygotes (6) . The current study was designed to examine whether peripheral blood monocytes, whose oxygen metabolism during phagocytosis involves both mitochondrial and nonmitochondrial pathways (7) , would show differences among C F patients, their parents, and controls in oxygen radical production. As a sensitive indicator of oxygen radical production we studied the amount of luminol-amplified CL (8-1 I) generated when the purified peripheral blood monocytes of CF patients, carriers, and their age-sex matched controls were stimulated by opsonized zymosan, PMA, or by adherence to the sides of glass liquid scintillation vials (12) .
METHODS
Human subjects. After informed consent, four groups of individuals were studied. Each individual was compared with a simultaneously examined age-sex matched control selected from the normal population. This study was approved by the Human Subjects Committee at the University of Minnesota.
Group one consisted of 15 CF patients between the ages of 2 and 40. All had elevated sweat chloride levels by the method of Gibson and Cooke (13) . All had had evidence of pancreatic insufficiency. Most were regularly receiving bronchodilators, pancreatic enzyme replacement, and antibiotic therapies. All patients had their pancreatic insufficiency controlled at the time of study. FVC varied from 38 to 124% predicted (median = 67%), FEV, from 23 to 114% predicted (median = 39%) FEV,/ FVC from 0.38 to 0.87 (median = 0.6 1) and Brasfield scores (14) from 1 to 19 (median score = 12) at the time of study.
Group two was comprised of 21 parents of CF patients, i.e. obligate C F carriers. Nine of these were parents 0 f -C~ patients who were diagnosed within 1 wk prior to testing. Thus, these individuals were obligate CF camers who had less exposure to environmental factors associated with living with and caring for a patient with CF such as medications and bacterial flora common in the sputum produced by older patients with CF. These factors could conceivably alter the parents' monocyte CL.
Group three consisted of 11 people who routinely cared for CF patients but were biologically unrelated. Included were two respiratory therapists, four spouses of CF patients, one private day care attendant, and six foster or adoptive parents. These individuals were routinely exposed to CF environmental factors but were not known CF camers.
To determine whether obstructive lung disease and the use of bronchodialators and antibiotics by these patients could alter CL, a fourth group of 13 individuals without evidence of C F but with obstructive pulmonary disease were studied. Eight had chronic obstructive pulmonary disease with FEV,/FVC < 0.80 and chronic cough. Five had asthma with obstructive pulmonary disease significantly reversible by p-agonists.
Individuals with evidence of acute or chronic bacterial infection were excluded from groups two, three, and the control group. They were not excluded from group four. Individuals who had symptoms of acute viral infection or who were immunodeficient were excluded from the study.
Monocytepreparation. Monocytes were purified using preconditioned plastic flasks as previously described (15, 16) . The resulting cells were at least 95% monocytes by nonspecific esterase staining and greater than 90% viable by the trypan blue exclusion method.
Fifty-one of the 67 adherence assays were performed without the technician knowing whether samples were from experimental or control individuals. Before identifying the donors, data pairs were rejected if the raw CPM for any given vial was less than two times the background levels, or if their coefficient of variation from duplicates exceeded 30%.
Chemiluminescence assays. To measure zymosan-induced CL, 2 x lo4 monocytes suspended in 1 ml HBSS with 0.1 % gelatin (w/v) were added to duplicate scintillation vials containing zymosan, preopsonized in pooled human serum for 10' at 37" C and 1.3 pM luminol in 4.5 ml HBSS. Vials were counted in a Beckman LS 100 scintillation counter using an open window and one photomultiplier tube set out of coincidence. They were counted approximately every 4.1 min until after the peak in light flux.
PMA-induced CL was measured in the same manner as zymosan-induced CL, but 2.2 pg PMA in place of zymosan was added to vials containing 4.5 ml HBSS with 1.3 mM luminol.
To measure adherence-induced CL, 2.5 x lo5 monocytes in 1 ml HBSS were added to vials containing 1.3 pM luminol in 4.5 ml HBSS. Because the presence of protein can inhibit leukocyte adherence to glass (12) , no gelatin was present in the reaction mixture. All vials had been dark-adapted, background CL levels had been recorded, and all monocytes were added in the dark. When allowed to adhere to glass liquid scintillation vials (Fig.  l) , monocytes from the 11 CF patients and 21 CF carriers, generated significantly higher early CL than their respective matched controls (Fig. 2) [mean difference from control in peak Fig. 1 . Adherence-induced CL: a single experiment. Normal controls were age-and sex-matched to the CF patient and carrier. Glass adherence produced an early plateau or initial small peak occuning before 25 min, followed by a gradual increase in light production per adherent monocyte. Discrimination between CF patients, carriers, and controls was obtained by comparing the initial peaks or the highest rate of light production within the first 25 min using a two-tailed paired t test. cells, SEM = 1.2 x lo4, n = 15, P,(t) = 0.331. Nor was there a significant difference in adherent CF camer monocytes at 25' compared to control [mean difference = -0.73 x lo4 cells, SEM = 0.37 x lo4, n = 21, P,(t) = 0.061. To control for environmental influences, nine of these camers who were parents of newly diagnosed patients were separately analyzed and they too generated significantly higher CL [mean difference from control in peak CPM/cell + 1 SEM = 0.78 k 0.33, p,(t) = 0.0451. Moreover, when all carriers were analyzed there was no association between the difference in CPM from control and the length of time they were exposed to a CF patient.
Finally, monocytes from caretakers of CF patients who were not biologically related to them (group 3) showed no difference from matched controls in their adherence-induced CL [mean Interestingly, the five patients with asthma had a small but significantly decreased adherence-induced CL compared to their matched controls [mean difference in peak CPM per adherent cell f 1 SEM = -0.40 + 0.12 p,(t) = 0.031 and none had CL above that of his matched control. In both of these groups the probability (P) of not detecting a difference as large as that seen between CF camers and controls was 5 10%.
DISCUSSION
During phagocytosis, peripheral blood monocyte oxygen consumption increases dramatically (7, 17) . This oxygen is rapidly converted into superoxide anion, hydrogen peroxide, and hydroxyl radical via one and two electron transfers to oxygen, with concurrent oxidation of NADH or NADPH (16) . These oxygen products can be measured with high efficiency by luminoldependent chemiluminescence assays (8) (9) (10) 18) . Luminol, however, will emit detectable photons whenever it is oxidatively dioxygenated (19) . Thus, oxidants other than oxygen radicals, per se, might be responsible for the effects we observed. For example, peroxidases present in freshly isolated monocytes will likely produce HOCl from H202 and C1-. The combination of HOCl and H202 significantly increases the C1 from luminol over that with H202 generating systems alone. Moreover, OH-, 02-, and '02 do not seem critical to the production of luminol CL by HOCl with H202 (20) . The major alternative source to oxidase generated oxygen radicals and peroxidase products would be Fig. 2 . Adherence-induced CL: each point represents the peak CPMladherent monocyte for each CF patient connected to his/her age-and sexmatched control's value. Values are based on duplicate determinations after background CL was subtracted. Similarly, each parental carrier's peak CPM/adherent monocyte is connected to his/her age-and sex-matched control's value. For statistical analysis of the differences see Figure 3 . products of arachidonic acid cyclooxygenase and endoperoxidation. This pathway has been shown to be active in CL generated by platelets on exposure to exogenous fatty acids (2 1). However, the efficiency of the interaction of these products with luminol to produce CL has not been defined and no exogenous fatty acids were added in our system. Our results therefore suggest that during the first 25 min after adherence to glass liquid scintillation vials, monocytes from CF patients and CF camers either generated increased amounts of oxygen radicals when compared with normals or secreted more enzyme(s) such as peroxidase that would catalyze the generation of oxygen radicals. However, monocytes from CF carriers and normals generated essentially equivalent amounts of these putative oxygen radicals when stimulated with opsonized zymosan or PMA. This difference among differing stimuli could relate to differences in membrane-surface interaction, membrane receptor-surface interaction, ionic flux, second messenger stimulation, compartmentalization of the oxidases involved in the oxygen radical formation (22) , or differences in the oxidase pathways. Further investigation by use of other stimuli, alternative luminogenic probes, and metabolic inhibitors is currently underway.
It should be emphasized that the CL difference between CF patients and controls and between CF camers and controls were produced by monocytes that had been purified by adhering to preconditioned plastic flasks. It is possible that this step selected a particular monocyte subset and/or activated the surface membrane of these monocytes permitting the detection of these differences from control. However, since there was no difference in the application of this purification technique to any of the experimental or control groups, the technique itself cannot explain the differences in CL we have observed.
Our finding of increased CL of CF and CF camer phagocytic cells is consistent with the finding that CF and CF carrier fibroblasts show increased O2 uptake and a variant NADH dehydrogenase (6), but we have no direct evidence at this time that this particular enzyme system is involved in the phenomenon we have observed. The significance of this early increase in presumed oxygen radical formation and/or release for host defense against microbes or for oxidative damage to host tissues remains to be defined.
The fact that the phenotypically normal parents of patients with CF showed an increase in adherence-induced CL and that the differences from control did not vary with age or length of exposure of a carrier to a child with CF argue strongly that this phenomenon is not simply secondary to either the medications or the respiratory dysfunction seen in the patients with CF; the fact that patients with other types of obstructive lung disease did not show an increase also indicates that it may be unique to CF. Moreover, repeated exposure to medications and respiratory secretions of CF patients was not associated with an increase in adherenced-induced CL in monocyte samples from their nonbiologically related caretakers nor did the biological parents of patients with CF show increasing adherence CL with increasing exposure time to the drugs and therapies prescribed for their children. We conclude that increased early phase adherenceinduced monocyte CL occurs in patients with C F and the obligate parental carriers of the CF gene independent of environmental influences.
